Nebivolol Ratiopharm (Nebivolol Hydrochloride)

Nebivolol, the active ingredient in Nebivolol Ratiopharm, is a beta blocker presented as an oral tablet for oral use. It treats hypertension and heart failure in adult patients. GNH USA supplies Nebivolol Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nebivolol is a selective β1‑adrenergic blocker used in cardiovascular disease management. - Hypertension: lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Heart failure: improves left‑ventricular function and reduces symptoms of chronic heart failure. - Cardiovascular risk reduction: may decrease the incidence of stroke and myocardial infarction in high‑risk patients.

Nebivolol is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often occurring early in therapy. - Dizziness: sensation of light‑headedness, especially when standing quickly. - Fatigue: feeling of reduced energy or tiredness. - Nausea: mild stomach upset or queasiness. - Bradycardia: slower than normal heart rate. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Severe bradycardia: markedly low heart rate requiring medical attention. - Symptomatic hypotension: significant drop in blood pressure causing faintness. - Atrioventricular block: impaired electrical conduction of the heart. - Bronchospasm: tightening of airway muscles, especially in patients with asthma. - Allergic reactions: rash, itching, swelling, or anaphylaxis. - Hepatic dysfunction: abnormal liver enzyme elevations.

Before initiating Nebivolol, consider patient‑specific factors and monitor appropriately. - Renal impairment: dose may need adjustment in reduced kidney function. - Hepatic impairment: use with caution; monitor liver enzymes. - Asthma or COPD: monitor for bronchospasm, as β‑blockade can exacerbate airway narrowing. - Concomitant AV‑nodal blockers: increased risk of profound bradycardia. - Pregnancy: safety not established; weigh potential benefits against risks. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nebivolol may interact with several drug classes; clinical judgment is required.

Major Interactions (Avoid): - Other beta‑blockers: additive bradycardia and hypotension. - Calcium‑channel blockers (verapamil, diltiazem): increased risk of AV‑block. - Clonidine: abrupt discontinuation can cause rebound hypertension.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may enhance hypotensive effect. - Diuretics: risk of orthostatic hypotension and electrolyte imbalance. - Antidepressants (SSRIs, SNRIs): may affect nebivolol metabolism via CYP2D6. - Antidiabetic agents: may mask hypoglycemia symptoms.